V001-2132 Screening compound: 2-{[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]formamido}-3-methyl-N-[(pyridin-3-yl)methyl]butanamide

V001-2132 Screening compound: 2-{[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]formamido}-3-methyl-N-[(pyridin-3-yl)methyl]butanamide
V001-2132 Screening compound: 2-{[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]formamido}-3-methyl-N-[(pyridin-3-yl)methyl]butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-2132
2-{[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]formamido}-3-methyl-N-[(pyridin-3-yl)methyl]butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-2132

Molecular Formula

C23H26N4O3 (C23 H26 N4 O3)

Compound Name

2-{[5-(2,5-dimethylphenyl)-1,2-oxazol-3-yl]formamido}-3-methyl-N-[(pyridin-3-yl)methyl]butanamide

IUPAC name

2-{[5-(25-dimethylphenyl)-12-oxazol-3-yl]formamido}-3-methyl-N-[(pyridin-3-yl)methyl]butanamide

SMILES

CC(C)C(C(NCc1cnccc1)=O)NC(c1noc(-c2c(C)ccc(C)c2)c1)=O

InChI

InChI=1S/C23H26N4O3/c1-14(2)21(23(29)25-13-17-6-5-9-24-12-17)26-22(28)19-11-20(30-27-19)18-10-15(3)7-8-16(18)4/h5-12,14,21H,13H2,1-4H3,(H,25,29)(H,26,28)/t21-/m0/s1

InChI Key

RXQSFHNQVCNLIJ-NRFANRHFSA-N

MDL Number (MFCD)

MFCD19813346

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

406.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.096

Distribution Coefficient, logD

3.094

Water Solubility, LogSw

-2.95

Polar Surface Area

79.742

Acid Dissociation Constant (pKa)

13.66

Base Dissociation Constant (pKb)

5.15

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.40

V001-2132 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Regenerative Medicine Focused Library (23016 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Endocrine
Targets:
  • Others
Mechanism of action:
  • Epigenetic
  • PPI modulators

References: we are preparing a list of scientific research reports with V001-2132 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-2132?
Check Price and Availability of V001-2132, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-2132 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-2132
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-2132
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-2132 available by request